PLUR
PLUR
NASDAQ · Biotechnology

Pluri Inc

$1.24
+0.05 (+3.82%)
As of Nov 7, 2:41 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.32M
Net Income
-30,830,930
Gross Margin
44.6%
Profit Margin
-2,344.6%
Rev Growth
+131.9%
D/E Ratio
250.29
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 44.6% 48.9% 30.3% 30.3%
Operating Margin -2,454.5% -1,493.9% -1.4% -1.5%
Profit Margin -2,344.6% -1,605.8% -1.8% -1.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.32M 1.18M 4.21M 5.36M
Gross Profit 586.5K 575.4K 1.28M 1.62M
Operating Income -32,285,954 -17,559,971 -59,264 -77,809
Net Income -30,830,930 -17,884,542 -76,163 -75,826
Gross Margin 44.6% 48.9% 30.3% 30.3%
Operating Margin -2,454.5% -1,493.9% -1.4% -1.5%
Profit Margin -2,344.6% -1,605.8% -1.8% -1.4%
Rev Growth +131.9% +78.7% +17.4% +13.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 7.76M 12.36M 10.60M 10.10M
Total Equity 31.0K 49.4K 12.82M 11.60M
D/E Ratio 250.29 250.29 0.83 0.87
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -31,615,355 -17,808,595 -73,642 -95,229
Free Cash Flow — — -41,548 -57,067